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Objectives: To examine gender differences in sexual behaviour, the prevalence of laboratory-detected
sexually transmitted infections (STIs) and self-reported genital symptoms in urban Chennai, Tamil Nadu,
India.
Study design: The data were based on a cross-sectional survey (n = 1649) of residents from low-income
communities in Chennai. Data were collected during community-wide health camps comprising physical
examinations, interviews and laboratory testing between March and June 2001.
Results: The population was young, sexually active, with a low prevalence of STI. The most commonly
detected STI was Herpes simplex virus type 2 (HSV2; 13.2%). Women had a higher prevalence of HSV2,
but were more likely than men to be asymptomatic. Most of the self-reported genital symptoms could not
be linked to a laboratory-detected STI. .10% of the cohort had a history of an ulcerative STI and .5% had
an inflammatory STI.
Conclusions: Given a high prevalence of HSV2 in the study population, interventions targeting HSV2
transmission may be particularly relevant for this population.
S
exually transmitted infections (STIs) are common in
developing countries,1 posing a major health burden for
women aged 15–44 years2 who are more likely to be
asymptomatic and have serious complications, such as pelvic
inflammatory disease, leading to infertility and ectopic
pregnancies.3 There has been increasing evidence for the
synergy between STI and HIV infection. Studies have
established that women have a higher biological risk for
contracting STIs and HIV than men, with a higher probability
of transmission from men to women than vice versa.3 After
adjusting for sexual behaviour, STIs have been shown to
increase the transmissibility of HIV through sexual contact by
3–5 times ,4 5 as STI and HIV alter the transmission or
manifestations of the other.6 Consequently, STI prevention
and control is a priority in HIV prevention efforts in the
developing countries, including India, which has the second
highest number of HIV-infected people in the world after
South Africa.7–12
Owing to a lack of a fully-functional STI surveillance
system in India, prevalence estimates for STI are varied.13 For
example, one study detected an STI prevalence of 22% in
women attending a reproductive health clinic in New Delhi,14
and the overall community-based prevalence of STI among
women and men was 8.3% in a ‘‘probability proportional to
size’’ cluster survey in three randomly selected districts in
Tamil Nadu.15 In studies based on random community-based
samples, Trichomonas vaginalis was the most commonly found
STI (5%),15 16 followed by Neisseria gonorrhoeae (3–4%),15 16
Chlamydia trachomatis and herpes simplex virus type 2 (HSV2)
(1–1.4%),15 17 and Treponema pallidum (syphilis) being the
least prevalent (about 0.3%).15 16 18
STI transmission patterns have conformed to the cultural
patterns of gender expression in the Indian society,13 such as
culturally imposed silence about discussing sex,19 unequal
norms about sexual morality, rights, power and educational
opportunities between the sexes,19–23 and changing tradi-
tions.24 25 For married women in India, HIV and STI
transmission has been largely attributed to a spouse who
had multiple partners,5 26 27 male resistance to condom use
and women’s inability to negotiate safer sex.28
The current data are derived from an epidemiological
survey conducted in preparation for a prospective National
Institute of Mental Health collaborative STI–HIV prevention
trial in Chennai, which has been designed to test the efficacy
of community popular opinion leaders in disseminating
prevention messages to their peers. This cross-sectional
preliminary survey presents a unique opportunity to study
the gender differences in the prevalence of symptoms and
diagnoses of STI in a community-based random sample of
low-income women and men living in Chennai. The specific
aims of this paper are to examine gender differences in the
number of sexual partners, determine STI prevalence in this




The site of this cross-sectional study was Chennai, Tamil
Nadu, India, on the southeast coast of India, in urban
communities designated as ‘‘slum communities’’ by the
Tamil Nadu Slum Clearance Board
Data collection and analyses
Data were collected through a community-based behavioural
assessment survey between March and June 2001. Of the 976
slums listed by the Tamil Nadu Slum Clearance Board, 30
were selected based on size (,300 families/slum) and
interest of local residents’ in implementing and managing
the study. All residents of the selected 30 slum communities
were enumerated in a census survey. Subsequently, 65
households were selected from each community using
Abbreviations: HSV, herpes simplex virus; NIMH, National Institute of
Mental Health; STI, sexually transmitted infection
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systematic random sampling and one 18–40-year-old person
from each of the selected households was selected by simple
random sampling to participate in a survey nested in health
camps that were conducted free of charge for all slum residents,
which included free physical examinations, laboratory testing,
standard medicines and appropriate referrals.
After completing voluntary informed consent, selected
participants at the health camps provided information on
their health status, sexual behaviour, STI history and health-
seeking behaviours. Of the total 1950 eligible people, 1649
(84.6%) participated in interviews and provided biological
specimens for laboratory testing. Information was collected
in Tamil language by trained same-sex interviewers using
computer-assisted personal interviewing technology.
Participants were requested to provide blood, urine and
cervical samples for women, and all underwent HIV pretest
counselling. The informed consent forms and all other
procedures were approved by the institutional review boards
of the Johns Hopkins University Bloomberg School of Public
Health (Baltimore, Maryland, USA) and the YR Gaitonde
Centre for AIDS Research and Education (Chennai, Tamil
Nadu, India).
Stata V.8.0 (Stata Corporation, College Station, Texas,
USA) was used to analyse quantitative data. Means and
proportions yielded descriptive statistics. x2 tests and
Mantel–Haenszel common odds ratio estimates (from simple
and multivariate logistic regression) were computed for
bivariate and multivariate analysis. Detailed analysis was
undertaken after stratifying the data by sex to examine
differences with regard to STI symptoms. Additionally, self-
reported symptoms were compared with laboratory diagnosis
for both women and men. Demographics and prevalence of
STI were determined in the total study population; however
the analysis comparing the presence of STI with symptoms
was restricted to sexually active participants. Information
was incomplete for 29 participants, hence they were omitted
from analysis, yielding a final sample of 1620 participants.
Laboratory methods
Amplicor multiplex polymerase chain reaction test (Roche
Diagnostics, Branchburg, New Jersey, USA) was used to
detect Neisseria gonorrhoeae and Chlamydia trachomatis.
Trichomonas vaginalis infection was detected using the
InPouch culture kit (Biomed Diagnostics, White City,
Oregon, USA), and HerpeSelect 2 ELISA (MRL; Focus
Technologies, Los Angeles, California, USA) was used to
detect immunoglobulin (Ig) G to HSV2 using 1.1 as the cut-
off point as per the manufacturer’s instructions. RPR (Span
Diagnostics, Surat, Gujarat, India) and TPPA (Serodia,
Fujirebio, Japan) were used to test for and confirm
Treponema pallidum infections. For HIV diagnosis, a double
Enzyme Linked Immuno Sorbent Assay was performed using
Abbott HIV 1.2.0 (Murex Biotech Limited, Kent, UK) and
Genscreen HIV 1/2 V.2 (Biorad Laboratories, Marnes La
Coquette, France), and all dual-positive and discordant
specimens were confirmed using western blot analysis
(Biorad Laboratories, Marnes La Coquette, France).
RESULTS
Demographics
The cohort was 53% female, with a mean age of 28 (standard
deviation 6.77) years; the age distribution in the sample was
similar in men and women (table 1). Women were more
likely be married than men (77.8% v 62.7%, p,0) and were
less educated than men (p,0.001)
Sexual partners
In all 77% of men reported lifetime sexual activity compared
with 89% of women (p,.001; table 1). Women and men in
the sample differed significantly on the number of lifetime
sexual partners and regular partners in the year preceding the
interview (p,.001). Almost half (47%) of men reported >2
lifetime partners compared with only 7% of women (odds
ratio (OR): 12.9, 95% confidence interval 8.85 to 18.87, after
controlling for age, marital status, education); and men were
more likely to report .1 regular partner than women (4.2% v.
0.1%, p,0.001). Of the women who had sex in the last year,
only 3 (0.6%) reported sex with a casual partner compared
with 20.9% of men who had sex with a casual partner in the
past year.
Prevalence of self-reported STI symptoms and STI
Overall, 13.3% and 2.3% of the respondents reported a genital
discharge and genital sores, respectively, in the week before
study visit, and the prevalence of symptoms differed by sex
Table 1 Demographics and number of sexual partners
from a random sample of men and women (n = 1620)
from low-income communities of Chennai, Tamil Nadu,









18–25 290 (37.7) 329 (39.1) 619 (38.4)
26–30 181 (23.5) 226 (26.8) 407 (25.3)
31–35 146 (19.0) 153 (18.2) 299 (18.6)
36–40 152 (19.8) 134 (15.9) 286 (17.8)
Marital status
Never married 271 (35.2) 103 (12.1) 374 (23.1)
Currently single 16 (2.0) 86 (10.2) 102 (6.3)
Married 483 (62.7) 661 (77.8) 1144 (70.6)
Education
Incomplete primary 117 (15.2) 267 (31.4) 384 (23.7)
Completed primary 179 (23.2) 129 (15.2) 308 (19.0)
High school graduate 178 (23.1) 202 (23.8) 380 (23.5)
College or graduate
degree
296 (38.4) 252 (29.6) 548 (33.8)
Sexual activity in lifetime
Yes 592 (76.9) 753 (88.6) 1345 (83.0)
No 178 (23.1) 97 (11.4) 275 (17.0)
Lifetime sexual partners,`
1 310 (52.6) 699 (93.3) 1009 (75.4)
>2 279 (47.4) 50 (6.7) 329 (24.6)
Sexual partners in the past
year
0 95 (16.1) 63 (8.4) 158 (11.75)
1 412 (69.6) 686 (91.1) 1098 (81.6)
>2 85 (14.4) 4 (0.5) 89 (6.6)
Regular sexual partners in past
year1
0 29 (5.9) 0 (0.0) 29 (2.4)
1 445 (89.9) 689 (99.9) 1134 (95.7)
>2 21 (4.2) 1 (0.1) 22 (1.9)
Casual sexual partners in past year
0 40 (43.5) 1 (33.3) 41 (43.2)
1 20 (21.7) 1 (33.3) 21 (22.1)
>2 32 (34.8) 1 (33.3) 33 (34.7)
Values are n (%).
*Data missing for age on nine respondents.
p,0.001.
`Sexually active respondents only, data missing for seven participants
(n = 1338).
1Sexually active respondents, who had sex in past year, 495 men
(missing data for two men) and 690 women.
Sexually active respondents, who have had sex in past year with other
than just regular partner, 92 men (missing data for 12 men) and 3
women (one refused to answer).
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(table 2); however, laboratory-detected STI did not differ by
sex (table 2). The most common STIs were HSV2 (13.2%) and
trichomoniasis (6.7% in women), whereas all the others were
present in (1% of the study population. Multivariate
analyses showed that women were much more likely to
report genital discharge (OR 11.8, 95% CI 6.2 to 22.3),
whereas men more often reported genital sores (OR 3.5, 95%
CI 1.4 to 8.8) after controlling for age, marital status,
education and number of partners in the past year.
Comparison of self-reported symptoms with
laboratory results for STI prevalence among sexually
active respondents
Subsequent analyses were conducted on a subsample of only
sexually active respondents. In all, 15 (2.7%) of the men who
were sexually active reported genital discharge in the week
preceding the interview, but none tested positive for either
gonorrhoea or chlamydia; whereas, none of the men who
tested positive for chlamydia or gonorrhoea (0.6%) reported a
discharge in the prior week. Although 22.3% of the sexually
active women reported genital discharge in the past week, 6%
did not test positive for chlamydia, gonorrhoea or trichomo-
nas. However, only 22.2% of the women actually having these
STIs (6.6% of the women in the study) showed symptoms.
For women, 33.3% of gonococcal infections were sympto-
matic, 22.5% of trichomoniasis were symptomatic, whereas
none of the chlamydial infections was symptomatic.
Table 2 Prevalence of genital discharge, sores, genital
inflammatory infections (gonorrhoea, chlamydia and
trichomoniasis), genital ulcerative infections (herpes
simplex virus 2 and syphilis) and HIV in the study
population (n = 1620) of men and women from a







Genital discharge* 15 (2.1) 180 (23.5) 195 (13.3)
Genital sores* 25 (3.6) 9 (1.2) 34 (2.3)
Overall STI prevalence` 89 (11.6) 144 (16.9) 233 (14.4)
Gonorrhoea 3 (0.4) 3 (0.4) 6 (0.4)
Chlamydia 4 (0.5) 2 (0.2) 6 (0.4)
Trichomoniasis1 Not tested 45 (6.7) 45 (6.7)
HSV2* 78 (10.1) 136 (16.0) 214 (13.2)
Syphilis 8 (1.0) 9 (1.1) 17 (1.0)
HIV 8 (1.0) 2 (0.2) 10 (0.6)
Values are n (%)
*Missing data on self-reported discharge or sores in the past week on 69
men and 84 women.
HSV, herpes simplex virus; STI, Sexually transmitted infections.
p,0.001.
`Not including HIV or trichomoniasis in women.
1 Data on trichomoniasis laboratory results missing on 174 women.
p,0.05.
Key messages
N Low-income urban communities in Chennai, Tamil
Nadu, India, have a high prevalence of herpes simplex
virus type 2(HSV2), which is higher in women than in
men.
N Women in this setting have a higher biological and
social vulnerability to sexually transmitted infection and
HIV infection.
N Screening and treatment for HSV2 infections may be
particularly appropriate for low-income urban settings
in south India, and could potentially reduce HIV
transmission.
Table 3 Gender-based and combined prevalence of sexually transmitted infection, by
symptoms, among the sexually active study respondents, in a random sample of men and
women (n = 1345) from low-income communities of Chennai, Tamil Nadu, India, from
March to June 2001
Men Women Total
Asymp Symp Asymp Symp Asymp Symp
STIs causing discharge
Total (n = 1227)* 531 (97.3) 15 (2.7) 529 (77.7) 152 (22.3) 1060 (86.4) 167 (13.6)
No infection (NG, CT
and Trich 2ve)1
528 (97.2) 15 (2.8) 31 (77.5) 9 (22.5) 559 (95.9) 24 (4.1)
Only NG (NG +ve,
CT and Trich 2ve)
0 (0) 0 (0) 2 (66.7) 1 (33.3) 2 (66.7) 1 (33.3)
Only CT (CT +ve, NG and Trich
2ve)
2 (100.0) 0 (0) 1 (100.0) 0 (0) 3 (100.0) 0 (0)
Only Trich (Trich +ve,
NG and CT 2ve)
0 (0) 0 (0) 31 (77.5) 9 (22.5) 31 (77.5) 9 (22.5)
Any discharge STI
(NG or CT or Trich +ve) 3 (100.0) 0 (0) 35 (77.8) 10 (22.2) 38 (79.2) 10 (20.8)
STIs causing sores
Total (n = 1228) 524 (96.0) 22 (4.0) 674 (98.8) 8 (1.2) 1198 (97.6) 30 (2.4)
No infection
(HSV2 and syphilis 2ve)1
457 (97.0) 14 (3.0) 543 (98.7) 7 (9.3) 1000 (97.9) 21 (2.1)
Only HSV2 infection
(HSV2 +ve, and syphilis 2ve) 61 (88.4)` 8 (11.6)` 122 (99.2) 1 (0.8) 183 (95.3) 9 (4.7)
Only syphilis infection
(Syphilis +ve and HSV2 2ve) 4 (100.0) 0 (0) 5 (100.0) 0 (0) 465 (97.1) 14 (2.9)
Any sore STI (HSV2 or
syphilis +ve) 67 (89.3) 8 (10.7) 131 (99.2) 1 (0.8) 198 (95.7) 9 (4.3)
Values are n (%).
-ve, negative; +ve, positive; Asymp, asymptomatic; CT, chlamydia; HSV2, herpes simplex virus type 2; NG,
gonorrhoea; STI, sexually transmitted infection; Symp, symptomatic; Trich, trichomoniasis.
*Missing data on 118 sexually active respondents for the presence of genital discharge in the past week.
Missing data on 117 sexually active respondents for the presence of genital sores in past week.
`p,0.05.
1Reference groups.
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In all, 4% of sexually active men reported genital sores in
the past week compared with 1.2% of women. However, 3.0%
of the men and 9.3% of the women who reported sores in the
past week did not test positive for HSV2 or syphilis. Only
10.7% of the men and 0.8% of the women who had HSV2
antibodies or syphilis showed symptomats.
DISCUSSION
This study describes the prevalence of STI and genitourinary
symptoms in a community-based random sample of primar-
ily young sexually active women and men from low-income
communities in India. Men were much more likely than
women to have .1 lifetime sexual partners, and to have
concurrent regular and casual partner. Despite measures to
conduct interviews in private cubicles in the health camps to
ensure confidentiality, there is also the possibility that
women under-reported their number of sexual partners
owing to social desirability bias, which is a possible limitation
in all studies of this nature.
The most common STI in this cohort was HSV2 infection in
men and women, and trichomoniasis in women. A large
proportion of men and women reported the presence of
genital discharge and sores in the past week without finding
the most commonly diagnosed genitourinary symptoms. We
are unable to conclude from these findings, whether frequent
reports of symptoms without laboratory confirmation was
due to the inability to correctly recognise symptoms or that
most symptoms were due to other infections (eg, bacterial
vaginosis or genital mycoplasma), sexual trauma or other
conditions. However, the findings highlight the benefit of
screening programmes that do not rely on reports of
morbidity.29 30
One of the most important findings is that 13% of this
community-based cohort tested positive for HSV2 antibodies,
which was a much higher prevalence than found in a
previous community-based study in Tamil Nadu (1.0% men
and 1.4% women).15 However, both studies show a higher
HSV2 prevalence in women, underscoring the need for
attention to the detection and treatment of HSV2 infections
in India.
Although most women reported only one lifetime partner,
they tended to often have HSV2 and trichomoniasis detected,
pointing to their vulnerability to infections from their
partners, because of both biological and social factors. The
high prevalence of HSV2 may increase susceptibility to HIV
and other genital infections in this population.31–33 A possible
limitation of this study is that recent studies have questioned
whether cut-offs for FOCIS HSV2 tests ought to be higher.34–36
However, the focus of this paper was to describe gender
differences in the prevalence of STIs and morbidity in this
southern Indian urban cohort that was clearly at high risk on
the basis of self-report and other STI markers. Further studies
on a culturally appropriate behavioural intervention in this
population will need to consider using higher readings for
HSV2 end points to avoid the overestimation of HSV2
prevalence and incidence in this population.
Given the unequal gender relationships in the Indian
society, it is possible that despite knowledge of extramarital
risky sexual behaviours of their male partners, many women
were often unable to negotiate safe sexual practices, resulting
in increased susceptibility to infection. Additionally, owing to
lack of symptoms, women may have not been able or
motivated to seek treatment for infections. These findings
indicate a need for prospective STI screening to detect silent
infections in women. Interventions oriented to altering risk-
taking behaviours in men in these communities may
facilitate HIV–STI prevention and control, for them and their
female partners.
In summary, the early detection and treatment of STI
through screening, and behavioural interventions focusing
on men, along with public health education and the
promotion of health-seeking behaviours, are critical for the
ultimate success of STI–HIV prevention programmes in
southern India.
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